We are live on ! Find out more
BBI

Baxter Bros Inc Portfolio holdings

AUM $810M
1-Year Est. Return 16.24%
This Fund
S&P 500
This Quarter Est. Return
-15.37%
1 Year Est. Return
+16.24%
3 Year Est. Return
+68.81%
5 Year Est. Return
+86.22%
10 Year Est. Return
+312.36%
AUM
$557M
AUM Growth
-$109M
Cap. Flow
+$590K
Cap. Flow %
0.11%
Top 10 Hldgs %
44.95%
Holding
134
New
3
Increased
41
Reduced
48
Closed
8

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.04M
2
T icon
AT&T
T
+$768K
3
SBUX icon
Starbucks
SBUX
+$366K
4
PYPL icon
PayPal
PYPL
+$334K
5
TRP icon
TC Energy
TRP
+$324K

Sector Composition

Rank Sector Weight
1 Technology 27.63%
2 Financials 22.67%
3 Communication Services 13.87%
4 Industrials 12.81%
5 Healthcare 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
76
Amgen
AMGN
$198B
$744K 0.13%
3,057
-18
-0.6% -$4.41K
UNH icon
77
UnitedHealth
UNH
$387B
$728K 0.13%
1,417
-83
-6% -$41.7K
ATCO
78
DELISTED
Atlas Corp.
ATCO
$725K 0.13%
67,660
-7,800
-10% -$98K
CHD icon
79
Church & Dwight Co
CHD
$23.2B
$722K 0.13%
7,795
-175
-2% -$16.5K
DE icon
80
Deere & Co
DE
$161B
$719K 0.13%
2,400
IDXX icon
81
Idexx Laboratories
IDXX
$44.8B
$659K 0.12%
1,880
CRM icon
82
Salesforce
CRM
$140B
$585K 0.11%
3,544
+413
+13% +$73K
NKE icon
83
Nike
NKE
$64.9B
$530K 0.1%
5,182
-120
-2% -$14.2K
CB icon
84
Chubb
CB
$137B
$523K 0.09%
2,662
-50
-2% -$10.3K
CSX icon
85
CSX Corp
CSX
$94.3B
$512K 0.09%
17,602
-15
-0.1% -$489
KMB icon
86
Kimberly-Clark
KMB
$36B
$502K 0.09%
3,715
CTAS icon
87
Cintas
CTAS
$81.8B
$465K 0.08%
4,976
COP icon
88
ConocoPhillips
COP
$140B
$449K 0.08%
4,997
-165
-3% -$17K
MKL icon
89
Markel Group
MKL
$24.7B
$447K 0.08%
346
+40
+13% +$54.9K
ALL icon
90
Allstate
ALL
$64.3B
$431K 0.08%
3,400
IMGN
91
DELISTED
Immunogen Inc
IMGN
$391K 0.07%
87,000
C icon
92
Citigroup
C
$217B
$390K 0.07%
8,488
+227
+3% +$11.4K
AZO icon
93
AutoZone
AZO
$49.7B
$387K 0.07%
180
CSCO icon
94
Cisco
CSCO
$441B
$387K 0.07%
9,071
-629
-6% -$30.1K
EMR icon
95
Emerson Electric
EMR
$78.2B
$375K 0.07%
4,720
-700
-13% -$61.7K
ABT icon
96
Abbott
ABT
$175B
$368K 0.07%
3,387
-107
-3% -$12.2K
VRTX icon
97
Vertex Pharmaceuticals
VRTX
$123B
$356K 0.06%
1,264
-175
-12% -$46.8K
SHEL icon
98
Shell
SHEL
$242B
$334K 0.06%
6,395
ABBV icon
99
AbbVie
ABBV
$450B
$329K 0.06%
2,145
-6,784
-76% -$1.04M
PARA
100
DELISTED
Paramount Global Class B
PARA
$326K 0.06%
13,192

Similar funds

Baxter Bros Inc's Q2 2022 Portfolio in Review

As of Q2 2022, Baxter Bros Inc held 134 positions worth $557M, down 16% from $666M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Baxter Bros Inc's Q2 2022 filing shows 3 new, 41 increased, 48 reduced and 8 closed positions. Its largest new stake was Charles Schwab: 3,837 shares worth $242K. The largest sale was AbbVie, an estimated $1.04M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Communication Services.

  • Baxter Bros Inc's largest Q2 2022 buy was Charles Schwab: 3,837 shares worth $242K.
  • Baxter Bros Inc added most to Franchise Group, Inc. in Q2 2022, an estimated $853K increase.
  • Baxter Bros Inc's biggest Q2 2022 reduction was AbbVie, cutting an estimated $1.04M.
  • Baxter Bros Inc fully exited Starbucks in Q2 2022, selling an estimated $366K.
  • Baxter Bros Inc's ten largest holdings make up 45% of its $557M portfolio in Q2 2022.
  • Baxter Bros Inc opened 3 new positions and closed 8 in Q2 2022.
  • Baxter Bros Inc's portfolio value fell 16% quarter-over-quarter to $557M.

Based on Baxter Bros Inc's 13F filing for Q2 2022, filed 25 Jul 2022.